Literature DB >> 17189869

Bedside neuropathy disability score compared to quantitative sensory testing for measurement of diabetic neuropathy in children, adolescents, and young adults with type 1 diabetes.

Naomi Weintrob1, Iris Amitay, Pearl Lilos, Shlomit Shalitin, Liora Lazar, Zeev Josefsberg.   

Abstract

BACKGROUND: While regular yearly screening for diabetic retinopathy and nephropathy is well established in patients with diabetes mellitus, there are no standardized diagnostic tests for diabetic peripheral neuropathy (DPN). In the present study, we compared the bedside neuropathy disability score (NDS) with quantitative sensory testing (QST) for screening for DPN in youth with type 1 diabetes mellitus.
METHODS: One hundred sixty-six patients aged 10 to 34 years (median 21 years) were evaluated for DPN by the NDS and QST. Quantitative sensory testing was also done in 43 healthy, age-matched controls. Diabetic peripheral neuropathy grade by both methods was correlated with disease-related variables.
RESULTS: On QST, the diabetic group had significantly higher mean scores for vibration (P<.001) and warm sensation (P<.01) than controls, and lower scores for cold sensation (P<.05); however, there was a great degree of overlap. The NDS significantly correlated with the vibration threshold, but not with the warm and cold thresholds. The NDS significantly correlated with age at testing, diabetes duration, and long-term and current HbA1c levels (P<.001), and with the presence of microalbuminuria and diabetic retinopathy (P<.001). Analysis of the QST variables yielded significant correlations of vibration and warm sensation with age at testing (P<.001, P<.05, respectively) and of vibration with diabetes duration (P<.001) and retinopathy (P=.05); none of the quantitative tests correlated with glycemic control.
CONCLUSIONS: The stronger association of the NDS with glycemic control and other microvascular complications compared to the perception thresholds, and its shorter time of performance and lack of costly equipment, may make the NDS the preferred method for measuring DPN in this population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17189869     DOI: 10.1016/j.jdiacomp.2005.11.002

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  22 in total

Review 1.  Treatment of painful diabetic neuropathy.

Authors:  Saad Javed; Ioannis N Petropoulos; Uazman Alam; Rayaz A Malik
Journal:  Ther Adv Chronic Dis       Date:  2015-01       Impact factor: 5.091

Review 2.  A systematic review of the prevalence, risk factors and screening tools for autonomic and diabetic peripheral neuropathy in children, adolescents and young adults with type 1 diabetes.

Authors:  Roberto Franceschi; Enza Mozzillo; Francesca Di Candia; Francesco Maria Rosanio; Letizia Leonardi; Alice Liguori; Francesca Micheli; Vittoria Cauvin; Adriana Franzese; Claudia Anita Piona; M Loredana Marcovecchio
Journal:  Acta Diabetol       Date:  2022-01-28       Impact factor: 4.280

Review 3.  [Quantitative sensory testing for neuropathic pain and its relevance for physiotherapy].

Authors:  Magdalena Adler; Bernhard Taxer
Journal:  Schmerz       Date:  2021-08-23       Impact factor: 1.107

Review 4.  Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.

Authors:  Saad Javed; Uazman Alam; Rayaz A Malik
Journal:  Rev Diabet Stud       Date:  2015-08-10

5.  Clinical assessment of peripheral neuropathy in HIV-infected children on antiretroviral therapy in rural South Africa.

Authors:  Remco P H Peters; Mette S Van Ramshorst; Helen E Struthers; James A McIntyre
Journal:  Eur J Pediatr       Date:  2014-04-02       Impact factor: 3.183

6.  Sudoscan is an effective screening method for asymptomatic diabetic neuropathy in Chinese type 2 diabetes mellitus patients.

Authors:  Fei Mao; Siying Liu; Xiaona Qiao; Hangping Zheng; Qian Xiong; Jie Wen; Lianyong Liu; Mingming Tang; Shuo Zhang; Zhaoyun Zhang; Hongying Ye; Bin Lu; Yiming Li
Journal:  J Diabetes Investig       Date:  2016-10-05       Impact factor: 4.232

7.  Prevalence and related risk-factors of peripheral neuropathy in children with insulin-dependent diabetes mellitus.

Authors:  Nasibeh Hasani; Saeid Khosrawi; Mahin Hashemipour; Mania Haghighatiyan; Zahra Javdan; Mohamad Hadi Taheri; Roya Kelishadi; Massoud Amini; Reihaneh Barekatein
Journal:  J Res Med Sci       Date:  2013-02       Impact factor: 1.852

8.  Letter to the Editor Regarding: Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study.

Authors:  Kalliopi Pafili; Nikolaos Papanas
Journal:  Adv Ther       Date:  2016-09-26       Impact factor: 3.845

9.  Comparison of electrochemical skin conductance and vibration perception threshold measurement in the detection of early diabetic neuropathy.

Authors:  Amit Goel; Channabasappa Shivaprasad; Anish Kolly; Vijaya Sarathi H A; Sridevi Atluri
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

10.  Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study.

Authors:  Mamta Jaiswal; Jasmin Divers; Dana Dabelea; Scott Isom; Ronny A Bell; Catherine L Martin; David J Pettitt; Sharon Saydah; Catherine Pihoker; Debra A Standiford; Lawrence M Dolan; Santica Marcovina; Barbara Linder; Angela D Liese; Rodica Pop-Busui; Eva L Feldman
Journal:  Diabetes Care       Date:  2017-07-03       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.